Loading...
Dose tailoring of human cell line‐derived recombinant factor VIII simoctocog alfa: Using a limited sampling strategy in patients with severe haemophilia A
AIMS: The use of factor VIII (FVIII) prophylaxis in haemophilia A is considered the standard of care, particularly in children. Despite adjustment of doses for body weight and/or age, a large pharmacokinetic (PK) variability between patients has been observed. PK‐tailored prophylaxis may help clinic...
Na minha lista:
| Udgivet i: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6422655/ https://ncbi.nlm.nih.gov/pubmed/30633808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13858 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|